ATRS - Antares Pharma - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $1.78. This is a potential upside of $1.78 (0%) from yesterday's end of day stock price of $0.

Antares Pharma's activity chart (see below) currently has 38 price targets and 27 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.5% with an average time for these price targets to be met of 265 days.

Most recent stock forecast was given by ELLIOT WILBUR from RAYMOND JAMES on 14-Apr-2022. First documented stock forecast 08-Oct-2013.

Best performing analysts who are covering ATRS - Antares Pharma:

Anthony Petrone Oren Livnat David Amsellem Elliot Wilbur Gregg Gilbert

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

6

$0.41 (7.33%)

6

2 years 10 days ago

0/3 (0%)

$0.44 (7.91%)

Hold

5.6

$0.01 (0.18%)

6

2 years 10 days ago

2/4 (50%)

$0.04 (0.72%)

374

Hold

2 years 10 days ago

7/8 (87.5%)

$1.2 (31.58%)

367

Hold

7

2 years 11 days ago

0/1 (0%)

$2.85 (68.67%)

Buy

8

$2.41 (43.11%)

7

5 years 5 months 18 days ago

2/4 (50%)

$4.39 (121.61%)

584

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATRS (Antares Pharma) average time for price targets to be met?

On average it took 265 days on average for the stock forecasts to be realized with a an average price target met ratio 37.5

Which analyst has the current highest performing score on ATRS (Antares Pharma) with a proven track record?

ANTHONY PETRONE

Which analyst has the current lower performing score on ATRS (Antares Pharma) with a proven track record?

GREGG GILBERT

Which analyst has the most public recommendations on ATRS (Antares Pharma)?

Anthony Petrone works at MIZUHO and has 7 price targets and 4 ratings on ATRS

Which analyst is the currently most bullish on ATRS (Antares Pharma)?

Anthony Petrone with highest potential upside - $2.41

Which analyst is the currently most reserved on ATRS (Antares Pharma)?

Gregg Gilbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?